Bavarian Nordic Transactions in Connection with Share Buy-Back Program
COPENHAGEN, Denmark, June 8, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces…
Press Release: Sanofis venglustat accepted for priority review in the US to treat type 3 Gaucher disease
Sanofi’s venglustat accepted for priority review in the US to treat type…
Allarity Therapeutics Reports First Quarter 2026 Results and Continued Stenoparib Development in Multiple Cancers
- Stenoparib clinical development continues in relapsed small cell lung cancer and,…
Disclosure of transparency notification from BlackRock, Inc.
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 28 April 2026 – 6 PM…
Press Release: ESCMID: Sanofi’s Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head…
Press Release: Sanofi and Regenerons Dupixent approved in Japan as the first targeted medicine to treat adults with bullous pemphigoid
Sanofi and Regeneron’s Dupixent approved in Japan as the first targeted medicine…
Disclosure of a transparency notification from Aberdeen Group plc
Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 20 March 2026 – 6 PM…
Tecan to create Data-Driven Labs with NVIDIA
Männedorf, Switzerland, March 17, 2026 – The Tecan Group (SIX Swiss Exchange:…
Fagron publishes its Annual Report 2025
Regulated informationNazareth (Belgium)/Rotterdam (The Netherlands), 6 March 2026 7AM CET Fagron publishes…
